Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. (HKG:1349)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
3.080
+0.050 (1.65%)
At close: Mar 6, 2026

HKG:1349 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
-1,0561,1961,2891,209
Short-Term Investments
---30-
Cash & Short-Term Investments
1,1191,0561,1961,3191,209
Cash Growth
5.90%-11.67%-9.35%9.13%-13.46%
Accounts Receivable
-469.96620.49679.12672.49
Other Receivables
-0.070.165.141.18
Receivables
-470.03620.64684.26673.66
Inventory
-47.2743.6540.5335.63
Other Current Assets
-33.29.2425.19.77
Total Current Assets
-1,6071,8692,0691,928
Property, Plant & Equipment
-503.53475.33351.51301.92
Long-Term Investments
-257.49287.53306.37327.86
Other Intangible Assets
-68.6586.3562.3288.46
Long-Term Deferred Tax Assets
-133.28100.8785.979.22
Long-Term Deferred Charges
---43.0936.12
Other Long-Term Assets
-16.7757.1857.6219.64
Total Assets
-2,5872,8772,9762,781
Accounts Payable
-10.678.057.438.17
Accrued Expenses
-28.6936.8634.6753.78
Short-Term Debt
---101-
Current Portion of Leases
-6.16.338.228.68
Current Income Taxes Payable
--1.611.6310.4
Current Unearned Revenue
-8.340.260.31348.87
Other Current Liabilities
-197.16451.9520.0998.3
Total Current Liabilities
-250.95505.02673.34528.2
Long-Term Leases
-14.4310.9515.622.59
Long-Term Unearned Revenue
-15.852.1534.0440.8
Total Liabilities
-281.23518.12722.99591.58
Common Stock
-103.66103.66102.9104.3
Additional Paid-In Capital
-1,2901,2891,2251,265
Retained Earnings
-916.9970.46934.39868.43
Treasury Stock
-----40.82
Comprehensive Income & Other
--5.55-5.86-5.2-4.05
Total Common Equity
2,2582,3052,3582,2572,193
Minority Interest
-0.711.01-4.08-3.36
Shareholders' Equity
2,2592,3052,3592,2532,190
Total Liabilities & Equity
-2,5872,8772,9762,781
Total Debt
15.9520.5317.28124.8131.26
Net Cash (Debt)
1,1031,0361,1791,1941,178
Net Cash Growth
6.46%-12.12%-1.33%1.43%-14.49%
Net Cash Per Share
1.061.001.141.161.13
Filing Date Shares Outstanding
1,0371,0371,0371,0291,032
Total Common Shares Outstanding
1,0371,0371,0371,0291,032
Working Capital
-1,3561,3641,3961,400
Book Value Per Share
2.182.222.272.192.12
Tangible Book Value
2,1942,2362,2712,1952,104
Tangible Book Value Per Share
2.122.162.192.132.04
Buildings
-368.53199.22198.52198.52
Machinery
-504.91388.63341.74322.86
Construction In Progress
-7.2229.96122.3748.9
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.